SC1011 Twice Daily vs Placebo in Patients Diagnosed With Idiopathic Pulmonary Fibrosis (IPF)

Clinical trial NCT06125327 · RECRUITING

Trial details

NCT number: NCT06125327
Sponsor: Guangzhou JOYO Pharma Co., Ltd
Status: RECRUITING
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Idiopathic Pulmonary Fibrosis

Start date: 2023-06-06
Primary completion: 2026-12-31
Enrollment: 210

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.